De la Caffinière thumb trapeziometacarpal joint arthroplasty: 16–26 year follow-up

Abstract

Seventy-one patients (93 implants) had a de la Caffinière prosthesis implanted between 1980 and 1989 and were reviewed and reported in 1997. We reviewed this series 10 years later. Similar outcome measures were used as in the original study, pinch and grip strength measured and validated outcome scores obtained (DASH and EQ-5D). Radiographic outcome was assessed. Twenty-six patients with 39 implants were available for review at a mean of 19 years (range, 16-26 years). Survivorship at 26 years was 73.9% (95% CI, 61.2 to 86.6) for re-operation and 26.0% (95% CI, 0 to 52.7) for all failure. Patients had satisfactory power and thumb mobility and continued to be satisfied without pain. Registries should log such prostheses and add to implant survival data.

Ten-year long-term results of total joint arthroplasties with ARPE® implant in the treatment of trapeziometacarpal osteoarthritis

“…This study demonstrates that the ARPE thumb CMC joint prosthesis is a reliable option for patients with thumb CMC arthritis of Stage III and for some patients of Stage IV of the Eaton classification in patients with medium-high level of functional demand. As suggested by others (Johnston et al, 2012), it should also be emphasized that there is a need to create a joint registry to record implant failure and revision rates.…”

Clinical and radiological outcomes of the Ivory arthroplasty for trapeziometacarpal joint osteoarthritis with a minimum of 5 years of follow-up: a prospective single-centre cohort study

“…Van Capelle et al (1999) and Chakrabarti et al (1997) reported a survival of greater than 16 years (72% and 89%, respectively) for the de la Caffinière prosthesis. Johnston et al (2012) Table 2. Results of measurements of radiological displacement of the implant (see Figure 4).…”

Management of Osteoarthrosis of the Thumb Joints

“…43 However, satisfactory power, thumb mobility, and pain relief were present in 74% of patients at long-term follow-up. 43,44 In 1997, Calandruccio and Jobe 45 introduced a spherical implant made of yttrium-stabilized zirconia, called the Orthosphere. Based on nearly universal adverse radiographic findings at medium-term follow-up, the inventors discontinued use of the implant.…”